Home > Financial Ratios > WANBURY

WANBURY
Core EBITDA Growth

    Back to All Ratios
WANBURY is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

WANBURY Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 9.34203.06-34.5980.29-16.93

What is the latest Core EBITDA Growth ratio of WANBURY ?

The latest Core EBITDA Growth ratio of WANBURY is 9.34 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20259.34
Mar2024203.06
Mar2023-34.59
Mar202280.29
Mar2021-16.93

How is Core EBITDA Growth of WANBURY Trending?

Years Core EBITDA Growth % Change
Mar2025 9.34
-95.40
Mar2024 203.06
Positive
Mar2023 -34.59
Negative
Mar2022 80.29
Positive
Mar2021 -16.93 -

Other Financial Ratios of WANBURY


Compare Core EBITDA Growth ratio of peers of WANBURY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WANBURY ₹850.9 Cr 12.8% 7.3% 23% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


WANBURY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WANBURY

12.8%

7.3%

23%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses